Health Care: Drugs

Clovis Oncology Inc (CLVS: NASDAQ)

$68.31 -2.01 | -2.86%
03/27/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 70.32
52 Week High 74.94
52 Week Low 11.57
Avg. Daily Vol. (Mil) 2.30
Beta (3 year) 1.86
Share Related Items
Mkt Cap (Mil) 3,138.13
Shares Out (Mil) 44.63
Float (Mil) 33.11
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.10
Current Ratio 4.30
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 40.23K
Price/Book 0.00
Price/Cash Flow -9.10
Per Share Data
Earnings -9.07
Sales 0.00
Book Value 0.00
Cash Flow -7.77
Business Summary
Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. Its commercial product is Rubraca.
General Information
5500 Flatiron Parkway
Suite 100
Boulder, CO 80301
Industry : Drugs
Sector: Health Care
Employees: 278
CEO: Patrick J. Mahaffy
Short Interest
Current Month (Mil) 7.67
Previous Month (Mil) 7.81
Short Interest Ratio (Days) 3.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -95.80
Return on Investments -125.80
Gross Margin 10.30
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CLVS

Latest CLVS Headlines from TheStreet

More Financial News for CLVS

Press Releases for CLVS

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter